PL199908A1 - METHOD OF MAKING NEW BLOCKING COMPOUNDS FOR H DOL 2 HISTAMINES - Google Patents

METHOD OF MAKING NEW BLOCKING COMPOUNDS FOR H DOL 2 HISTAMINES

Info

Publication number
PL199908A1
PL199908A1 PL19990877A PL19990877A PL199908A1 PL 199908 A1 PL199908 A1 PL 199908A1 PL 19990877 A PL19990877 A PL 19990877A PL 19990877 A PL19990877 A PL 19990877A PL 199908 A1 PL199908 A1 PL 199908A1
Authority
PL
Poland
Prior art keywords
histamines
dol
making new
blocking compounds
new blocking
Prior art date
Application number
PL19990877A
Other languages
Polish (pl)
Other versions
PL107847B1 (en
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PL199908A1 publication Critical patent/PL199908A1/en
Publication of PL107847B1 publication Critical patent/PL107847B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
PL1977199908A 1976-07-28 1977-07-28 METHOD OF PRODUCING NEW ALPHA-OMEGA DIGUANIDINOALKS METHOD OF PRODUCING NEW ALPHA, OMEGA TWOUGUANIDINEALKANOW ANES PL107847B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139176 1976-07-28

Publications (2)

Publication Number Publication Date
PL199908A1 true PL199908A1 (en) 1978-11-20
PL107847B1 PL107847B1 (en) 1980-03-31

Family

ID=10322405

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1977199908A PL107847B1 (en) 1976-07-28 1977-07-28 METHOD OF PRODUCING NEW ALPHA-OMEGA DIGUANIDINOALKS METHOD OF PRODUCING NEW ALPHA, OMEGA TWOUGUANIDINEALKANOW ANES

Country Status (15)

Country Link
JP (1) JPS5315370A (en)
AU (1) AU2734677A (en)
BE (1) BE857218A (en)
CA (1) CA1070315A (en)
DE (1) DE2733953A1 (en)
DK (1) DK331877A (en)
ES (1) ES461100A2 (en)
FI (1) FI772293A (en)
FR (1) FR2359840A1 (en)
IL (1) IL52544A0 (en)
LU (1) LU77845A1 (en)
NL (1) NL7708375A (en)
NO (1) NO772668L (en)
PL (1) PL107847B1 (en)
ZA (1) ZA774552B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309435A (en) * 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
FR2446829A1 (en) 1978-11-16 1980-08-14 Glaxo Group Ltd POLYMETHYLENE DERIVATIVES DISUBSTITUTED IN ALPHA, OMEGA, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Also Published As

Publication number Publication date
AU2734677A (en) 1979-02-01
DE2733953A1 (en) 1978-02-02
DK331877A (en) 1978-01-29
FI772293A (en) 1978-01-29
PL107847B1 (en) 1980-03-31
FR2359840A1 (en) 1978-02-24
ZA774552B (en) 1978-06-28
JPS5315370A (en) 1978-02-13
LU77845A1 (en) 1977-10-25
NL7708375A (en) 1978-01-31
ES461100A2 (en) 1978-12-01
IL52544A0 (en) 1977-10-31
CA1070315A (en) 1980-01-22
BE857218A (en) 1978-01-27
NO772668L (en) 1978-01-31

Similar Documents

Publication Publication Date Title
PL201586A1 (en) METHOD OF MAKING NEW SPIRO-HYDANTION COMPOUNDS
PL196505A1 (en) METHOD OF MAKING NEW AMINO-ALKYLETERCYCLIC COMPOUNDS
PL211753A1 (en) METHOD OF MAKING NEW 1,1-DIOXIDE-4-HYDROXY-2H-1,2-BENZOTHIAZINE-3-CARBOXYAMIDE
PL201286A1 (en) METHOD OF MAKING NEW 1-ARYLOXY-2-HYDROXY-3-ALKYLENE-AMINOPROPANE
PL200289A1 (en) METHOD OF MAKING 3-CHLOROCEPHEMIC COMPOUNDS
PL199533A1 (en) METHOD OF MAKING VIOLET TICL DOL 3
PL201837A1 (en) METHOD OF MANUFACTURING CINO-ORGANIC COMPOUNDS
PL200251A1 (en) METHOD OF MAKING NEW SUBSTITUTED 2-PHENYLAMINEIMIDAZOLINE- / 2 /
PL200583A1 (en) METHOD OF MAKING NEW BENZOPIRANE DERIVATIVES
PL200534A1 (en) METHOD OF MAKING NEW OXADESTIACHALOSPORINES
PL199909A1 (en) METHOD OF MAKING NEW BLOCKING COMPOUNDS FOR H DOL 2 HISTAMINES
PL200605A1 (en) METHOD OF MAKING NEW METHIONINOENKEPHALIN DERIVATIVES
PL199908A1 (en) METHOD OF MAKING NEW BLOCKING COMPOUNDS FOR H DOL 2 HISTAMINES
PL204041A1 (en) METHOD OF MAKING NEW 4 "-AMINOOLEANDOMYCIN DERIVATIVES
PL202660A1 (en) METHOD OF MAKING NEW DERIVATIVES OF SPIROOXAZOLIDYNODION
PL104866B1 (en) METHOD OF MAKING NEW PIRYDOBENZODWUAZEPINONOV
PL201839A1 (en) METHOD OF MANUFACTURING CINO-ORGANIC COMPOUNDS
PL201161A1 (en) METHOD OF MAKING NEW DERIVATIVES OF 9-CHLOROPREDISOLONE
PL196061A1 (en) METHOD OF MAKING NEW DERIVATIVES OF INDOLYSIN
PL201883A1 (en) METHOD OF MAKING NEW TRANS-5A-ARYL-CHABENZAZEPINE DERIVATIVES
PL197311A1 (en) METHOD OF MAKING NEW KETOTIA COMPOUNDS
PL206687A1 (en) METHOD OF MAKING NEW DERIVATIVES OF 4 "-DESOXY-4" -SULFONYLOOLEANDOMYCIN
PL203486A1 (en) METHOD OF MAKING NEW DERIVATIVES 6,7-DIMETOXY-1,2,3,4-TETRAHYDROGEN-1-ISOCHINOLINE-ACETAMIDE
PL196543A1 (en) METHOD OF MAKING NEW DERIVATIVES OF ASIRIDINE
PL200287A1 (en) METHOD OF MAKING 2,5-DIHYDROXYBENZENESULPHONATE